MARKET

SCLX

SCLX

Scilex Holding Co
NASDAQ
4.010
-0.380
-8.66%
After Hours: 4.020 +0.01 +0.25% 16:31 05/09 EDT
OPEN
4.380
PREV CLOSE
4.390
HIGH
4.540
LOW
3.950
VOLUME
185.29K
TURNOVER
--
52 WEEK HIGH
80.50
52 WEEK LOW
3.600
MARKET CAP
27.88M
P/E (TTM)
-0.2064
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SCLX last week (0428-0502)?
Weekly Report · 5d ago
Scilex regains compliance with Nasdaq minimum bid price rule
TipRanks · 04/30 17:56
Scilex Holding Company Regains NASDAQ Compliance With Minimum Bid Price Requirement
Benzinga · 04/30 17:48
SCILEX HOLDING COMPANY REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE RULE
Reuters · 04/30 17:46
Weekly Report: what happened at SCLX last week (0421-0425)?
Weekly Report · 04/28 10:31
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 04/22 17:05
Scilex Adjusts Record Date for Preferred Stock Dividend
TipRanks · 04/22 14:24
Scilex announces change in record date for dividend of preferred stock
TipRanks · 04/22 13:05
More
About SCLX
More
Scilex Holding Company is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company’s commercial products include ZTlidoO (lidocaine topical system) 1.8% for the relief of neuropathic pain associated with postherpetic neuralgia (PHN); ELYXYB, a ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults; and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. In addition, it focuses on product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXAO), an epidural injections formulation to treat lumbosacral radicular pain, or sciatica; SP-103 (lidocaine topical system) 5.4%, a ZTlido formulation, for the treatment of acute pain; and SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (SP-104) for fibromyalgia treatment.
Recently
Symbol
Price
%Change

Webull offers Scilex Holding Co stock information, including NASDAQ: SCLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCLX stock methods without spending real money on the virtual paper trading platform.